Cargando…

Update on the Cardiac Safety of Moxifloxacin

Cardiac safety was compared in patients receiving moxifloxacin and other antimicrobials in a large patient population from Phase II–IV randomized active-controlled clinical trials. Moxifloxacin 400 mg once-daily monotherapy was administered orally (PO) or sequentially (intravenous/oral, IV/PO). Acro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haverkamp, Wilhelm, Kruesmann, Frank, Fritsch, Anna, van Veenhuyzen, David, Arvis, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480699/ https://www.ncbi.nlm.nih.gov/pubmed/22873499 http://dx.doi.org/10.2174/157488612802715735

Ejemplares similares

Moxifloxacin Safety: An Analysis of 14 Years of Clinical Data
por: Tulkens, Paul M., et al.
Publicado: (2012)

Characterisation of Patients Receiving Moxifloxacin for Acute Bacterial Rhinosinusitis in Clinical Practice: Results from an International, Observational Cohort Study
por: Mösges, Ralph, et al.
Publicado: (2013)

Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results
por: Wilson, Robert, et al.
Publicado: (2012)

Moxifloxacin in Complicated Skin and Skin Structure Infections (cSSSIs): A Prospective, International, Non-Interventional, Observational Study
por: Bogner, Johannes R., et al.
Publicado: (2013)

A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections
por: Gyssens, Inge C., et al.
Publicado: (2011)

Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study
por: Schaper, N. C., et al.
Publicado: (2012)

Safety and tolerability of moxifloxacin for the treatment of disseminated BCGitis in children
por: Alsuhaibani, Mohammed, et al.
Publicado: (2019)

Moxifloxacin Concentration and Proteomic Analysis of Aqueous Humor in Human Uveitis Associated with Oral Moxifloxacin Therapy
por: Hinkle, David M, et al.
Publicado: (2017)

Moxifloxacin-warfarin interaction
por: Ji, Yan, et al.
Publicado: (2012)

Comparative Outcomes of Standard Perioperative Eye Drops, Intravitreal Triamcinolone Acetonide-Moxifloxacin, and Intracameral Dexamethasone-Moxifloxacin-Ketorolac in Cataract Surgery
por: Kuriakose, Robin K., et al.
Publicado: (2022)

Safety of intracameral application of moxifloxacin and dexamethasone (Vigadexa®) after phacoemulsification surgery
por: Galvis, Virgilio, et al.
Publicado: (2023)

Intravitreal moxifloxacin injections in acute post-cataract surgery endophthalmitis: Efficacy and safety
por: Agarwal, Abhishek, et al.
Publicado: (2021)

The role of moxifloxacin in tuberculosis therapy
por: Gillespie, Stephen H.
Publicado: (2016)

Meta-analysis on Effectiveness and Safety of Moxifloxacin in Treatment of Multidrug Resistant Tuberculosis in Adults
por: Guan, Yanmin, et al.
Publicado: (2020)

Moxifloxacin Increases Heart Rate in Humans
por: Mason, Jay W., et al.
Publicado: (2017)

Moxifloxacin in the treatment of skin and skin structure infections
por: Guay, David RP
Publicado: (2006)

Moxifloxacin and bilateral acute iris transillumination
por: Knape, Robert M, et al.
Publicado: (2013)

Recurrent episodes of hypoglycemia induced by moxifloxacin
por: Singal, Dinesh Kumar, et al.
Publicado: (2013)

Efficacy and safety of sequential IV/PO moxifloxacin for the treatment of severe community-acquired pneumonia
por: Lode, H, et al.
Publicado: (2002)

Three-photon tissue imaging using moxifloxacin
por: Lee, Seunghun, et al.
Publicado: (2018)

Decreased protein binding of moxifloxacin in patients with sepsis?
por: Dorn, Christoph, et al.
Publicado: (2017)

Corneal deposits following topical moxifloxacin use
por: Alshamrani, Abdulaziz A., et al.
Publicado: (2019)

Molecular Characterization and Moxifloxacin Susceptibility of Clostridium difficile
por: Mizrahi, Sarah, et al.
Publicado: (2019)

Case of Moxifloxacin-Induced Black Hairy Tongue
por: Kato, Mikiro, et al.
Publicado: (2022)

Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI)
por: Kuzman, Ilija, et al.
Publicado: (2014)

A Prospective Study of the Efficacy, Safety and Pharmacokinetics of Enteral Moxifloxacin in the Treatment of Hemodialysis Patients with Pneumonia
por: Tokimatsu, Issei, et al.
Publicado: (2017)

Moxifloxacin-Induced Thrombocytopenia Mediated by Moxifloxacin-Dependent IgM and IgG Antiplatelet Antibodies: A Case Report
por: Moore, Joel, et al.
Publicado: (2020)

Effect of hyperglycaemia in combination with moxifloxacin on cardiac repolarization in male and female patients with type I diabetes
por: Taubel, Jorg, et al.
Publicado: (2022)

Moxifloxacin (Avelox) Induced Thrombotic Thrombocytopenic Purpura
por: Surana, Sikander P., et al.
Publicado: (2012)

Evaluation of Moxifloxacin-induced Biochemical Changes in Mice
por: Ukpo, Grace E., et al.
Publicado: (2012)

Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
por: Miravitlles, Marc
Publicado: (2007)

Moxifloxacin modulates inflammation during murine pneumonia
por: Beisswenger, Christoph, et al.
Publicado: (2014)

Acute iris depigmentation following systemic moxifloxacin
por: do Nascimento, Heloisa Moraes, et al.
Publicado: (2013)

Moxifloxacin Induced Seizures -A Case Report
por: SHI, Jiana, et al.
Publicado: (2014)

Efficiency of Moxifloxacin in the Treatment of Helicobacter pylori Infection
por: Altun, Battal, et al.
Publicado: (2015)

Lithium Intoxication: A Possible Interaction with Moxifloxacin
por: Kayipmaz, Selvi, et al.
Publicado: (2017)

Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI)
por: Chuchalin, Alexander, et al.
Publicado: (2013)

The Effect of Conjugation of Ciprofloxacin and Moxifloxacin with Fatty Acids on Their Antibacterial and Anticancer Activity
por: Chrzanowska, Alicja, et al.
Publicado: (2022)

Moxifloxacin in situ gelling microparticles–bioadhesive delivery system
por: Guo, Qiongyu, et al.
Publicado: (2012)

Effects of Moxifloxacin on Human Neutrophil and T-Lymphocyte Functions in Vitro
por: Potjo, Moliehi, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_nnsppdhtuner85srq4287u52h4